OUR RESEARCH IN THE NEWS
Multiple sclerosis therapy improves gut flora
A medication used to treat MS also has a beneficial effect on the composition of the intestinal flora, according to researchers from the University of Basel and the University Hospital Basel. Conversely, the gut flora also plays a role in which side effects occur during treatment with the medication. More
Researchers discover a new function of the cerebellum
The cerebellum is known primarily for regulation of movement. Researchers at the University of Basel have now discovered that the cerebellum also plays an important role in remembering emotional experiences. More
Filippo Rijli elected to Accademia Nazionale dei Lincei
Filippo M. Rijli, group leader at the FMI and Professor in Neurobiology at the University of Basel, has been elected Member of the Italian Accademia Nazionale dei Lincei, one the world’s oldest and most prestigious scientific academies. More
SNSF Advanced Grant for Andreas Lüthi and Peter Scheiffele
The Swiss National Science Foundation has awarded Prof. Andreas Lüthi from the FMI and Prof. Peter Scheiffele from the Biozentrum, University of Basel, a highly endowed SNSF Advanced Grant. With the SNSF Advanced Grants, the SNSF supports leading scientists in Switzerland who take unconventional and often risky paths in their research to gain new insights. More
First ophthalmic gene therapy in Switzerland
We are proud to announce that the first ophthalmic gene therapy in Switzerland has been performed in the Eye Clinic of the University Hospital Basel. The gene therapy is available for patients with Leber congenital amaurosis and retinitis pigmentosa caused by mutations in the RPE65 gene – one out of 280 known disease genes that can cause retinal dystrophies. More
Multiple treatments to slow age-related muscle wasting
Everyone wants to stay fit and healthy as they grow old. But as we age, our body degrades, our muscles shrink and strength declines. Some older people suffer from excessive muscle loss, a condition known as sarcopenia. Researchers from the Biozentrum of the University of Basel show that a combination therapy could delay the onset of sarcopenia. This study has recently been published in “Nature Communications”. More
Brain Prize 2022 for Silvia Arber
Prof. Silvia Arber from the Biozentrum, University of Basel, and at the Friedrich Miescher Institute for Biomedical Research receives the renowned Brain Prize 2022. With this award, the Lundbeck Foundation recognizes this year's three prizewinners for their pioneering research into the neuronal circuits that control movement.
More
More news
Follow us on:
Upcoming Basel Seminars in Neuroscience
April 20th, 2023, 4 pm
Alison Barker (MPI)
Title to be announced
More
Upcoming events
Thursday, April 20th and Friday, April 21st 2023, Human brain course for Neuroscience graduate students
This course is a collaborative effort between the Neuroanatomical Departments of the University of Basel and the University of Freiburg and is supported by a grant from Eucor for stimulating collaboration between our Universities. Many graduate students do their thesis projects in the field of Neuroscience, some even in close relation to human neurological diseases. As most of the graduate students do not have a training in human medicine they were never exposed to human neuroanatomy. The aim of this course is to give these students an opportunity to study human anatomy in a lab course with human specimens and learn about the structures of the human brain which are mostly affected by neurological diseases.
More PDF-download
June 8th & 9th, 2023, Early-Career Researcher Symposium
Young Swiss Society for Neuroscience
Lugano, Switzerland Download PDF-Flyer
Friday June 9th and Saturday June 10th 2023
The 2023 Annual Meeting of the Swiss Society for Neuroscience (SSN) is organized by the Università della Svizzera Italiana (USI) in Lugano.
More information on https://www.swissneuroscience.ch/events/18/